Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Polyamidoamine dendrimers having poly(ethylene glycol) grafts were designed as a novel drug carrier which possesses an interior for the encapsulation of drugs and a biocompatible surface. Poly(ethylene glycol) monomethyl ether with the average molecular weight of 550 or 2000 was combined to essentially every chain end of the dendrimer of the third or fourth generation via urethane bond. The poly(ethylene glycol)-attached dendrimers encapsulating anticancer drugs, adriamycin and methotrexate, were prepared by extraction with chloroform from mixtures of the poly(ethylene glycol)-attached dendrimers and varying amounts of the drugs. Their ability to encapsulate these drugs increased with increasing dendrimer generation and chain length of poly(ethylene glycol) grafts. Among the poly(ethylene glycol)-attached dendrimers prepared, the highest ability was achieved by the dendrimer of the fourth generation having the poly(ethylene glycol) grafts with the average molecular weight of 2000, which could retain 6.5 adriamycin molecules or 26 methotrexate molecules/dendrimer molecule. The methotrexate-loaded poly(ethylene glycol)-attached dendrimers released the drug slowly in an aqueous solution of low ionic strength. However, in isotonic solutions, methotrexate and adriamycin were readily released from the poly(ethylene glycol)-attached dendrimers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dendrimers are commonly used as building blocks to prepare unimolecular micelles, because of their well-defined globular architecture, high-branching, and controlled surface functionality [156, 157].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [157]
Citations
Cites
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Self-citationMalik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Sterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Integration of Layered Redox Proteins and Conductive Supports for Bioelectronic Applications
Willner, I., & Katz, E. Y. (2000) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(20000403)39:7<1285::aid-anie1285>3.0.co;2-f · Cited by 949
Dendritic Molecules: Concepts, Syntheses, Perspectives
Newkome, G. R., Moorefield, C. N., & Vögtle, F. (1996) · Wiley eBooks · doi:10.1002/9783527614875 · Cited by 806
Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199601)30:1<53::aid-jbm8>3.0.co;2-q · Cited by 589
Starburst dendrimers. 5. Molecular shape control
Naylor, A. M., Goddard, W. A., Kiefer, G. E., & Tomalia, D. A. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00188a079 · Cited by 513
The "Stealth" Liposome: A Prototypical Biomaterial
Lasic, D. D., & Needham, D. (1995) · Chemical Reviews · doi:10.1021/cr00040a001 · Cited by 416
Research works printed but not linked: 23
- Fréchet J. M. J., 1994, Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science 263, 1710−1715
- Tomalia D. A., 1985, Polym. J. 17, 117−132
- Hawker C. J., 1992, J. Am. Chem. Soc., 4
- Jansen J. F. G. A., 1994, Encapsulation of guest molecules into a dendritic box. Science 266, 1226−1229
- Newkome G. R., 1991, Engl. 30, 1178−1180.
- Liu M., 1999, Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 2, 393−401
- Zhuo R. X., 1999, J. Controlled Release, 57
- Kono K., 1999, Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem. 10, 1115−1121
- Newkome G. R., 1991, Engl. 30, 1176−1178.
- Hawker C. J., 1993, J. Chem. Soc., Perkin Trans., 1
- Twyman L. J., 1999, Tetrahedron Lett., 40
- Jansen J. F. G. A., 1995, J. Am. Chem. Soc., 117
- Abuchowski A., 1977, J. Biol. Chem., 252
- Abuchowski A., 1977, J. Biol. Chem., 252
- Yokoyama M., 1991, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229−3236
- Blume B., 1990, Biochim. Biophys. Acta, 1029, 97
- Liu M., 2000, J. Controlled Release, 65
- Liu M., 1999, Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers. J. Polym. Sci. Part A: Polym
- Pan Y., 1999, Dendrimers with both hydrophilic and hydrophobic chains at every end. Macromolecules 32, 5468−5470
- Baars M. W., 2000, The localization of guests in water-soluble oligoethyleneoxy-modified poly(propylene imine) dendrimers
- Ritscher V. T. A., 1959, Makromol. Chem., 30, 80
- Kataoka K., 2000, J. Controlled Release 64, 143−153
- Abbreviations PAMAM, 2000, polyamidoamine
Cited by
Items 101–200 of 667
Targeted delivery of doxorubicin into cancer cells using a folic acid–dendrimer conjugate
Wang, Y., Cao, X., Guo, R., Shen, M., Zhang, M., Zhu, M., & Shi, X. (2011) · Polymer Chemistry · doi:10.1039/c1py00179e · Cited by 160
Colloidal soft matter as drug delivery system
Bonacucina, G., Cespi, M., Misici‐Falzi, M., & Palmieri, G. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21423 · Cited by 174
Cytotoxicity of Polypropylenimine Dendrimer Conjugates on Cultured Endothelial Cells
Stasko, N., Johnson, C. B., Schoenfisch, M. H., Johnson, T. A., & Holmuhamedov, E. (2007) · Biomacromolecules · doi:10.1021/bm7008203 · Cited by 156
Dendrimers: design, synthesis and chemical properties
Boas, U., Christensen, J. B., & Heegaard, P. M. H. (2006) · Journal of Materials Chemistry · doi:10.1039/b611813p · Cited by 153
Fu, F., Wu, Y., Zhu, J., Wen, S., Shen, M., & Shi, X. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504849x · Cited by 151
Macromolecular MRI contrast agents for imaging tumor angiogenesis
Barrett, T., Kobayashi, H., Brechbiel, M. W., & Choyke, P. L. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.06.025 · Cited by 150
“[79] Kojima C, Kono K, Maruyama K, Takagishi T.”
BackgroundDendrimers for Enhanced Drug Solubilization
Svenson, S., & Chauhan, A. S. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.679 · Cited by 149
“This efficiency for MTX was fourfold higher than that of DOX, reflecting the stronger interaction between negatively charged MTX molecules and the ammonium-containing core of the dendrimer; however, drug release from this dendrimer had the same challenge as observed for DOX, that is, sustained release at low ionic str…”
BackgroundInfluentialKobayashi, H., Kawamoto, S., Bernardo, M., Brechbiel, M. W., Knopp, M. V., & Choyke, P. L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.019 · Cited by 149
Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications
Mousa, S. A., & Bharali, D. J. (2011) · Cancers · doi:10.3390/cancers3032888 · Cited by 156
“The main advantage of dendrimers is their exclusive branching point that is available for conjugation to multiple entities [61], including targeting proteins, treatment moieties, and even apoptosis factor ligands.”
BackgroundCrampton, H. L., & Simanek, E. E. (2007) · Polymer International · doi:10.1002/pi.2230 · Cited by 146
Khandare, J. J., Kolhe, P., Pillai, O., Kannan, S., Lieh-Lai, M. W., & Kannan, R. M. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498018 · Cited by 144
Klajnert‐Maculewicz, B., Appelhans, D., Komber, H., Morgner, N., Schwarz, S., Richter, S., Brutschy, B., Йонов, М., Tonkikh, A. K., Bryszewska, M. J., et al. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800342 · Cited by 143
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2005966 · Cited by 143
Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability
Jain, N. K., & Gupta, U. D. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.8.1035 · Cited by 142
“Reports are available that compared the solubilising power of surface engineered dendrimers composed of different chain lengths of PEG [88-90] .”
BackgroundSoft‐Nanoparticle Functionalization of Natural Hydrogels for Tissue Engineering Applications
Elkhoury, K., Russell, C. S., Sanchez‐Gonzalez, L., Mostafavi, A., Williams, T. J., Kahn, C., Peppas, N. A., Arab‐Tehrany, E., & Tamayol, A. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900506 · Cited by 138
Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
Wijagkanalan, W., Kawakami, S., & Hashida, M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0339-8 · Cited by 139
“However, PEG with high MW of 5 kDa reduced the drug encapsulation due to the agglomeration of the PEG chain occupying the dendritic cavity available for drug molecules ( 45 ,73).”
BackgroundFunctionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy
Seidu, T. A., Kutoka, P. T., Asante, D. O., Farooq, M. A., Alolga, R. N., & Wang, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051113 · Cited by 139
Ryan, G. M., Kaminskas, L. M., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.051 · Cited by 141
“As a result of the stepwise synthetic methods used to generate the structures, dendrimers arewell defined in terms of molecular weight and branching, and typically have low polydispersity [113,115].”
MethodSoliman, G. M., Sharma, A., Maysinger, D., & Kakkar, A. K. (2011) · Chemical Communications · doi:10.1039/c1cc11981h · Cited by 152
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics
Kojima, C., Türkbey, B., Ogawa, M., Bernardo, M., Regino, C. A. S., Bryant, L. H., Choyke, P. L., Kono, K., & Kobayashi, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.007 · Cited by 144
“molecule compared with the standard molecule, PEG.(26) The hydrodynamic diameters (Table 1) were estimated from the GPC data according to our previous report.”
InfluentialSelf-citationTomalia, D. A. (2005) · Materials Today · doi:10.1016/s1369-7021(05)00746-7 · Cited by 154
Bundling and Aggregation of DNA by Cationic Dendrimers
Froehlich, E., Mandeville, J. S., Weinert, C. M., Kreplak, L., & Tajmir‐Riahi, H. A. (2010) · Biomacromolecules · doi:10.1021/bm1013102 · Cited by 133
A Review on Synthesis, Characterization and Applications of Copper Nanoparticles Using Green Method
Rafique, M., Shaikh, A. J., Rasheed, R., Tahir, M. B., Bakhat, H. F., Rafique, M., & Rabbani, F. (2017) · NANO · doi:10.1142/s1793292017500436 · Cited by 139
Bioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicine
Pourianazar, N. T., Mutlu, P., & Gündüz, U. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2342-1 · Cited by 132
“Then, activation of these photosensitizers by light of appropriate wavelength is performed, and they pass on their excess energy to nearby molecular oxygen to form reactive oxygen species such as singlet oxygen (1O2) and free radicals, which are toxic to cells and tissues (Kojima et al. 2007).”
BackgroundInfluentialFunctional dendritic polymer architectures as stimuli-responsive nanocarriers
Calderón, M., Quadir, M., Strumia, M. C., & Haag, R. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.017 · Cited by 130
Kesharwani, P., Tekade, R. K., & Jain, N. K. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1549-2 · Cited by 130
“However, alkaline pH causes collapse of dendrimer periphery on itself, known as ‘back folding’ (5,22).”
Molecular Engineering of Dendritic Polymers and Their Application as Drug and Gene Delivery Systems
Paleos, C. M., Tsiourvas, D., & Sideratou, Z. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060076n · Cited by 129
Kojima, C., Umeda, Y., Ogawa, M., Harada, A., Magata, Y., & Kono, K. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/24/245104 · Cited by 128
Self-citationRecent advances in dendrimer-based nanoplatform for cancer treatment: A review
Ambekar, R. S., Choudhary, M., & Kandasubramanian, B. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.109546 · Cited by 126
Appelhans, D., Komber, H., Quadir, M., Richter, S., Schwarz, S., van der Vlist, J., Aigner, A. M., Müller, M., Loos, K., Seidel, J., et al. (2009) · Biomacromolecules · doi:10.1021/bm801310d · Cited by 126
Cheng, Y., & Xu, T. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.12.021 · Cited by 124
Pharmaceutical and Biomedical Potential of PEGylated Dendrimers
Gajbhiye, V., Kumar, P. V., Tekade, R. K., & Jain, S. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780162999 · Cited by 134
Polyether based amphiphiles for delivery of active components
Gupta, S., Tyagi, R., Parmar, V. S., Sharma, S. K., & Haag, R. (2012) · Polymer · doi:10.1016/j.polymer.2012.04.047 · Cited by 132
Impact of pegylation on biopharmaceutical properties of dendrimers
Thakur, S., Kesharwani, P., Tekade, R. K., & Jain, N. K. (2015) · Polymer · doi:10.1016/j.polymer.2014.12.051 · Cited by 123
Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting
Ghaffari, M., Dehghan, G., Gaballu, F. A., Kashanian, S., Baradaran, B., Dolatabadi, J. E. N., & Lošić, D. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.020 · Cited by 126
Ye, C., & Chi, H. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.10.003 · Cited by 121
Dendrimeric Systems and Their Applications in Ocular Drug Delivery
Yavuz, B., Pehlivan, S. B., & Ünlü, N. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/732340 · Cited by 120
Folic Acid Conjugated Amino Acid-Based Star Polymers for Active Targeting of Cancer Cells
Sulistio, A., Lowenthal, J., Blencowe, A., Bongiovanni, M. N., Ong, L., Gras, S. L., Zhang, X., & Qiao, G. G. (2011) · Biomacromolecules · doi:10.1021/bm200604h · Cited by 128
Hydrogels with smart systems for delivery of hydrophobic drugs
Gu, D., O’Connor, A. J., Qiao, G. G., & Ladewig, K. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1245290 · Cited by 124
Xu, L. S., Chen, L., & Yang, H. (2013) · Chemical Communications · doi:10.1039/c3cc47484d · Cited by 117
Papagiannaros, A., Dimas, K., Papaioannou, G. T., & Demetzos, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.039 · Cited by 117
A Collagen-Mimic Dendrimer Capable of Controlled Release
Kojima, C., Tsumura, S., Harada, A., & Kono, K. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809639c · Cited by 113
Self-citationMan, N., Yiyun, C., Xu, T., Ding, Y., Xiaomin, W., Li, Z., Zhichao, C., Huang, G., Shi, Y., & Wen, L. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.01.001 · Cited by 113
Amphiphilic block co-polymers: Preparation and application in nanodrug and gene delivery
Xiong, X.-B., Binkhathlan, Z., Molavi, O., & Lavasanifar, A. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.006 · Cited by 124
Advances in the Elegance of Chemistry in Designing Dendrimers
Hourani, R., & Kakkar, A. K. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.200900712 · Cited by 111
Pan, B., Gao, F., & Ao, L. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.02.018 · Cited by 110
Kojima, C., Regino, C. A. S., Umeda, Y., Kobayashi, H., & Kono, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.015 · Cited by 108
Self-citationSohail, I., Bhatti, I. A., Ashar, A., Sarim, F. M., Mohsin, M. R., Naveed, R., Yasir, M., Iqbal, M., & Nazir, A. (2019) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2019.10.079 · Cited by 107
“[27] Kojima C, Kono K, Maruyama K, Takagishi T.”
BackgroundKannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R. M., Lieh-Lai, M. W., & Bassett, D. J. P. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856204322977201 · Cited by 107
Nanosystems for simultaneous imaging and drug delivery to T cells
Fahmy, T. M., Fong, P., Park, J. Y., Constable, R. T., & Saltzman, W. M. (2007) · The AAPS Journal · doi:10.1208/aapsj0902019 · Cited by 113
Reduction of Drug Toxicity Using Dendrimers Based on Melamine
Neerman, M. F., Chen, H., Parrish, A. R., & Simanek, E. E. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049957p · Cited by 106
Recent Advances in Star Polymer Design: Degradability and the Potential for Drug Delivery
Wiltshire, J. T., & Qiao, G. G. (2007) · Australian Journal of Chemistry · doi:10.1071/ch07128 · Cited by 117
A review of in vitro–in vivo investigations on dendrimers: the novel nanoscopic drug carriers
Gupta, U. D., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.002 · Cited by 106
“[60] Kojima C, Kono K, Maruyama K, Takagishi T.”
BackgroundKainthan, R. K., Mugabe, C., Burt, H. M., & Brooks, D. E. (2008) · Biomacromolecules · doi:10.1021/bm701208p · Cited by 102
Role of nanocarrier systems in cancer nanotherapy
Mozafari, M. R., Pardakhty, A., Azarmi, S., Jazayeri, J. A., Nokhodchi, A., & Omri, A. (2009) · Journal of Liposome Research · doi:10.3109/08982100902913204 · Cited by 107
“, 2003), methotrexate, and doxorubicin (Kojima et al., 2000), and slow the drug-release rates.”
BackgroundDendrimer-mediated approaches for the treatment of brain tumor
Dwivedi, N., Shah, J., Mishra, V. K., Amin, M. C. I. M., Iyer, A. K., Tekade, R. K., & Kesharwani, P. (2015) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2015.1133155 · Cited by 101
Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 100
“Drug release was also found to be controlled by molecular architecture (25) of dendrimer and introducing poly(ethylene oxide) chains on the periphery of the dendrimer (26,27).”
BackgroundEvaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid
Madaan, K., Lather, V., & Pandita, D. (2014) · Drug Delivery · doi:10.3109/10717544.2014.910564 · Cited by 100
“Furthermore, it has already been stated that the encapsulation of the quercetin molecule in dendrimers increased with increase in its generation (Kojima et al., 2000).”
BackgroundNandy, B., & Maiti, P. K. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp106776v · Cited by 98
Bagheri, M., Rodríguez, H., Swatloski, R. P., Spear, S. K., Daly, D. T., & Rogers, R. D. (2007) · Biomacromolecules · doi:10.1021/bm701023w · Cited by 97
Durairaj, C., Sistla, R., Ahmad, F. J., Khar, R. K., & Diwan, P. V. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31122 · Cited by 97
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications
Yellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903061251 · Cited by 105
“PEG may be attached to dendrimers either by forming covalent or electrostatic bonds [69,96,97].”
BackgroundBai, S., & Ahsan, F. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9769-y · Cited by 95
“This observation also agrees with previously published data that showed the pegylated dendritic micelles produce sustained release both in vitro and in vivo ( 19 ,20,29).”
BackgroundMethodResultInfluentialPolymer Micelles as Drug Carriers
Batrakova, E. V., Bronich, T. K., Vetro, J. A., & Kabanov, A. V. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0005 · Cited by 112
Adverse Effects of Engineered Nanomaterials Exposure, Toxicology, and Impact on Human Health
Howard, J., & Murashov, V. V. (2013) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3182882c46 · Cited by 93
Synergistic Supramolecular Encapsulation of Amphiphilic Hyperbranched Polymer to Dyes
Liu, C., Gao, C., & Yan, D. (2006) · Macromolecules · doi:10.1021/ma0608065 · Cited by 92
Türk, H., Shukla, A., Rodrigues, P. C. A., Rehage, H., & Haag, R. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200601337 · Cited by 99
Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery
Kakde, D. D., Kakde, R. B., Patil, A., Jain, D., & Shrivastava, V. (2011) · Cited by 126
Polymere Therapeutika: Konzepte und Anwendungen
Haag, R., & Kratz, F. (2006) · Angewandte Chemie · doi:10.1002/ange.200502113 · Cited by 108
Hui, H., Xiao-dong, F., & Zhong-lin, C. (2005) · Polymer · doi:10.1016/j.polymer.2005.07.034 · Cited by 91
Host−Guest Chemistry and Physicochemical Properties of the Dendrimer−Mycophenolic Acid Complex
Hu, J., Cheng, Y., Ma, Y., Wu, Q., & Xu, T. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp8078919 · Cited by 89
Dendrimers in medical nanotechnology
Barrett, T., RAVIZZINI, G. C., Choyke, P. L., & Kobayashi, H. (2009) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2008.931012 · Cited by 93
Past and future evolution in colloidal drug delivery systems
Boyd, B. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.69 · Cited by 88
Enhancement of entrapping ability of dendrimers by a cubic silsesquioxane core
Tanaka, K., Inafuku, K., Naka, K., & Chujo, Y. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b812349g · Cited by 89
Recent advances of zwitterionic-based topological polymers for biomedical applications
Zhang, M., Yu, P., Xie, J., & Li, J. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02323c · Cited by 89
Effect of dendrimer on entrapment and release of bioactive from liposomes
Khopade, A. J., Caruso, F., Tripathi, P. K., Nagaich, S., & Jain, N. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00901-2 · Cited by 87
Molecular Interactions of Dendrimers with Amyloid Peptides: pH Dependence
Klajnert‐Maculewicz, B., Cladera, J., & Bryszewska, M. J. (2006) · Biomacromolecules · doi:10.1021/bm060229s · Cited by 86
Shi, X., Lee, I., Chen, X., Shen, M., Xiao, S., Zhu, M., Baker, J. R., & Wang, S. H. (2010) · Soft Matter · doi:10.1039/b925274f · Cited by 86
Kojima, C., Suehiro, T., Watanabe, K., Ogawa, M., Fukuhara, A., Nishisaka, E., Harada, A., Kono, K., Inui, T., & Magata, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.11.013 · Cited by 91
Self-citationXu, S., Luo, Y., & Haag, R. (2007) · Macromolecular Bioscience · doi:10.1002/mabi.200700066 · Cited by 97
β-Cyclodextrin-Centered Star-Shaped Amphiphilic Polymers for Doxorubicin Delivery
Li, Q., Wang, R. J., Zheng, C., Jin, Y., & Jin, L. (2010) · Nanomedicine · doi:10.2217/nnm.09.108 · Cited by 86
Hyperbranched Polymer-Drug Conjugates with High Drug Payload for Enhanced Cellular Delivery
Kolhe, P., Khandare, J. J., Pillai, O., Kannan, S., Lieh-Lai, M. W., & Kannan, R. M. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7670-x · Cited by 85
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview
Crintea, A., Motofelea, A. C., Şovrea, A. S., Constantin, A.-M., Crivii, C. B., Carpa, R., & Duţu, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051406 · Cited by 88
Dhanikula, R. S., & Hildgen, P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.012 · Cited by 84
Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug
Abderrezak, A., Bourassa, P., Mandeville, J. S., Sedaghat‐Herati, R., & Tajmir‐Riahi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033102 · Cited by 86
Dendrimers as novel drug-delivery system and its applications
Patel, V., Rajani, C., Paul, D., Borisa, P., Rajpoot, K., Youngren-Ortiz, S. R., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00008-9 · Cited by 94
A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
Jin, Y., Ren, X., Wang, W., Ke, L., Ning, E., Du, L., & Bradshaw, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.053 · Cited by 83
Xu, S., Luo, Y., Graeser, R., Warnecke, A., Kratz, F., Hauff, P., Licha, K., & Haag, R. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.043 · Cited by 81
Nanomaterial-based ophthalmic drug delivery
Xie, G., Lin, S., Wu, F. Q., & Liu, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115004 · Cited by 81
Cheng, Y., Li, M., & Xu, T. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.09.030 · Cited by 80
Nguyen, T. T. C., Nguyen, C. K., Nguyen, T. H., & Trân, N. Q. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.073 · Cited by 82
Dendrimers in targeted drug delivery applications: a review of diseases and cancer
Mandal, A. K. (2020) · International Journal of Polymeric Materials · doi:10.1080/00914037.2020.1713780 · Cited by 83
Kono, K., Yoshino, K., & Takagishi, T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00018-4 · Cited by 79
Self-citationMultiarm star nanocarriers containing a poly(ethylene imine) core and polylactide arms
Adeli, M., & Haag, R. (2006) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.21664 · Cited by 79
Abdellatif, A. A. H., Mohammed, H. A., Khan, R. A., Singh, V., Bouazzaoui, A., Yusuf, M., Akhtar, N., Khan, M., Al-Subaiyel, A., Mohammed, S. A. A., et al. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0096 · Cited by 84
Unimolecular micelles based on hyperbranched polycarbohydrate cores
Satoh, T. (2009) · Soft Matter · doi:10.1039/b819748b · Cited by 85
Wang, S., Wang, X., Li, L., & Advíncula, R. C. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo0499773 · Cited by 78
Engler, A. C., Ke, X., Gao, S., Chan, J. M. W., Coady, D. J., Ono, R. J., Lubbers, R., Nelson, A., Yang, Y. Y., & Hedrick, J. L. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00156 · Cited by 81
Mohammadifar, E., Kharat, A. N., & Adeli, M. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02133a · Cited by 76
Yang, H., Lopina, S. T., DiPersio, L. P., & Schmidt, S. P. (2007) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3278-0 · Cited by 75
Metadata
- Authors
- Kojima, C., Kono, K., Maruyama, K., & Takagishi, T.
- Affiliations
- Osaka Prefecture University (JP)
- Corresponding author
- Kono, Kenji
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-11-01
- Volume
- 11
- Issue
- 6
- Pages
- 910-917
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2022549879
- Cited by
- 663
- References
- 17
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 20 · 2021: 12 · 2020: 23 · 2019: 19 · 2018: 16 · 2017: 26 · 2016: 31 · 2015: 37 · 2014: 40 · 2013: 45 · 2012: 47
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Shorai Foundation for Science and Technology
- Topics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- PAMAM dendrimers, drug encapsulation, drug carriers, doxorubicin, methotrexate, anticancer agents, dendrimer generation, drug loading, controlled drug release, chloroform extraction
- MeSH terms
- Antineoplastic Agents, Doxorubicin, Drug Carriers, Drug Compounding, Methotrexate, Magnetic Resonance Spectroscopy, Polyamines, Polyethylene Glycols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.